CTRI Number |
CTRI/2018/02/012156 [Registered on: 26/02/2018] Trial Registered Prospectively |
Last Modified On: |
12/07/2021 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
Study to Understand the Effect of Ayurvedic Management of Urinary Tract Infection |
Scientific Title of Study
|
Evaluation of Ayurvedic Management of Uncomplicated Urinary Tract Infections In Adult Females– Using Modern Biochemical Tests -A Pre-post,Pragmatic Clinical Study |
Trial Acronym |
UTI Study |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Neelambika GB |
Designation |
Surgical Registrar |
Affiliation |
Institute of Ayurveda and Integrative Medicine |
Address |
Institute of Ayurveda and Integrative Medicine
No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore
Bangalore KARNATAKA 560064 India |
Phone |
08028567310 |
Fax |
|
Email |
neelambika@iaimhealthcare.org |
|
Details of Contact Person Scientific Query
|
Name |
Dr Neelambika GB |
Designation |
Surgical Registrar |
Affiliation |
Institute of Ayurveda and Integrative Medicine |
Address |
Institute of Ayurveda and Integrative Medicine
No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore
Bangalore KARNATAKA 560064 India |
Phone |
08028567310 |
Fax |
|
Email |
neelambika@iaimhealthcare.org |
|
Details of Contact Person Public Query
|
Name |
Dr Neelambika GB |
Designation |
Surgical Registrar |
Affiliation |
Institute of Ayurveda and Integrative Medicine |
Address |
Institute of Ayurveda and Integrative Medicine
No.74by2,Jarakabandekaval,Post Attur,Via Yelahanka,Bangalore
Bangalore KARNATAKA 560064 India |
Phone |
08028567310 |
Fax |
|
Email |
neelambika@iaimhealthcare.org |
|
Source of Monetary or Material Support
|
Foundation of Revitalization of Local Health Traditions Trust,
74/2, Jarakbande Kaval, Post Attur, Via Yelahanka, Bengaluru, Karnataka 560064 |
|
Primary Sponsor
|
Name |
FRLHT Trust |
Address |
74/2, Jarakabande kaval, Attur post, Ramagondanahalli, Karnataka 560064 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Neelambika GB |
Institute of Ayurveda and Integrative Medicine |
Clinical research department, First floor, 74/2, Jarakabande kaval, Attur post, Ramagondanahalli, Karnataka 560064 Bangalore KARNATAKA |
8095459122
neelambika@iaimhealthcare.org |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committe for Human Research, Institute of Transdisciplinary Health Sciences and Technology |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
Adult female 18 to 59 years with diagnosed Urinary tract infection, (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Evaluation of Ayurvedic Management of Uncomplicated Urinary Tract Infections In Adult Females– Using Modern Biochemical Tests -A Pre-post,Pragmatic Clinical Study-[UTI Study] |
Based on the Ayurveda assessment of the patient combination of medications from the below mentioned will be prescribed: Punarnavaadi Kashayam, Thrinapanchamoola kashaya, Chandanoshiradi kashayam, Varanadi kashayam, Gokshuradiguggulu, Chandraprabhavati, Tab Cystone, Punarnava + Gokshura Paneeya, Combination of Churna+(Gokshura churna50gms+Manjishtachurna50gms+Yavakshara10gms+Hazralyahooda bhasma10gms)+ Panchavalkala kashayam (with or without tankana bhasma) + Usheerasava + Chandanasava + Saarivadyasava
Dosage of the drugs: Based on the assessment the patient combination of drugs appropriate for patient will be selected as per the guidelines of the classical Ayurveda text.No deviation from the classical texts will be done with respect to dosage and medication
Route of administration : Oral
Duration of therapy : 60 days. |
Comparator Agent |
Not applicable |
Not applicable |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
59.00 Year(s) |
Gender |
Female |
Details |
a.Female patients with clinical symptoms of UTI (frequency, urgency, burning micturition/dysuria, foul smelling urine, lower abdomen pain) aged between 18-59 years old.
b.Positive for pus cells(>6) along with Culture yielding >1000 CFU.
c.Patients who had not taken antimicrobials within the last 4 weeks.
|
|
ExclusionCriteria |
Details |
a.Upper UTI
b.Complicated cases of UTI such as Anatomical and physiological anomalies in urinary tract, any underline disease such as Calculi, impaired kidney function, Pyelonephritis, Diabetes mellitus etc.
c.Pregnant or nursing mother
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Primary
1.Reduction in number and severity of symptoms.
2.Reduction in number of pus cells- Pyuria- in urine
3.Reduction of Bacterial colony count.
|
60 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
Reduction in inflammatory markers - CRP and ESR |
60 days |
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="47" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
01/03/2018 |
Date of Study Completion (India) |
01/11/2019 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Study results will be published in peer reviewed journal and all rights of publications related to this study are with FRLHT. The sponsor has no conflict of interest. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
Modification(s)
|
Introduction: Urinary tract infections (UTIs) are one of the most common bacterial infections and a severe public health problem affecting 150 million people each year worldwide. Antibiotics are drug of choice to treat bacterial UTIs. Due to increasing incidence of antibiotic resistance, preventative approaches such as immune-modulation along with antimicrobial activity need to be encouraged more vigorously. Ayurvedic medicines/ herbs indicated in the texts have shown their efficacy in preventive care/ immune-modulation/ antimicrobial activity through the clinical studies, hence promising alternative of treating or reducing such infections. This exploration encourages us to evident Ayurvedic management for UTI through a defined clinical study. Ayurvedic drugs that would be used in the current study are being used in routine clinical practice and no known adverse reaction has been reported. Aim: To determine the efficacy of Classical Ayurvedic Management of uncomplicated UTI in adult females Single arm, Open labeled, non – randomized, pre-post clinical study Total duration of clinical study is 18 months Time point of data collection 1. Visit 1 - Baseline visit 2. Visit 2(15th day),3(at 30th day) and4(60th day) – Treatment and follow-up 3. Visit 5(120th day- it could be a telephonic interview-site visit is not mandatory) – Follow-up Primary end point of Study 1. Reduction in number and severity of symptoms. 2. Reduction in number of pus cells- Pyuria- in urine 3. Reduction of Bacterial colony count. Inclusion criteria a. Female patients with clinical symptoms of UTI (frequency, urgency, burning micturition/dysuria, foul smelling urine, lower abdomen pain) aged between 18-59 years old b. Positive for pus cells(>6) along with Culture yielding >1000 CFU c. Patients who had not taken antimicrobials within the last 4 weeks Exclusion criteria a. Upper UTI b. Complicated cases of UTI such as Anatomical and physiological anomalies in urinary tract, any underline disease such as Calculi, impaired kidney function, Pyelonephritis, Diabetes mellitus etc. c. Pregnant or nursing mother Efficacy/ effect Parameters Clinical symptoms and laboratory findings will be indicator of efficacy. Assessment will be made on following criteria during follow-up: 1. Changes in clinical symptoms 2. Bacterial colony count on urine culture 3. Changes in number of pus cells, ESR and CRP Benefit of study: This study will provide documentary proof of the efficacy of Ayurvedic management of UTI. Positive study results could make a big contribution for the society by reducing- 1. Unnecessary use of antibiotic that would lead to antibiotic resistance 2. Adverse effects due to repeated antibiotic usage 3. Burden of infection 4. Healthcare expenses |